ArticleBMJ open2021

Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry.

Stefan Braune et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.